MedTrace Logo

A Study of Duloxetine in the Treatment of Fibromyalgia

NCT00125892 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2007-05-17

No results posted yet for this study

Summary

This study is designed to evaluate duloxetine for the treatment of fibromyalgia syndrome patients.

Conditions

  • Fibromyalgia

Interventions

DRUG

duloxetine

Sponsors & Collaborators

Principal Investigators

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon-Fri 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Completion
2007-03-31

Countries

  • Argentina
  • Australia
  • Brazil
  • Canada
  • Mexico
  • Poland
  • Taiwan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00125892 on ClinicalTrials.gov